INLYTA vs IRESSA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 15, 2026·How we rate

Possible drug interaction. INLYTA and IRESSA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	INLYTA	IRESSA
Rating	New	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	AXITINIB	GEFITINIB
Manufacturer	Pf Prism Cv	Astrazeneca
Dosage forms	Tablet	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Renal Cell Carcinoma	Non-Small-Cell Lung Carcinoma

inlyta iressa

Rating

New

70/100

Pharmacy pays

—

Type

Active ingredient

AXITINIB

GEFITINIB

Manufacturer

Pf Prism Cv

Astrazeneca

Dosage forms

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Renal Cell Carcinoma

Non-Small-Cell Lung Carcinoma

Frequently asked questions

What is the difference between Inlyta and Iressa?

Inlyta contains Axitinib, while Iressa contains Gefitinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.